The high professional level of our center was confirmed during the sponsor's visit to evaluate the quality of a phase III clinical trial to assess the safety and immunogenicity of the drug GNR-086 conducted at our research center. Thank you for your comments and suggestions, which we will definitely take into account in our future work.
Our partners
